Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bruker Corp BRKR

Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. Its BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions... see more

Recent & Breaking News (NDAQ:BRKR)

Bruker Announces Quarterly Dividend

Business Wire February 17, 2023

Bruker Reports Fourth Quarter and Fiscal Year 2022 Financial Results

Business Wire February 9, 2023

Bruker Announces Successful Customer Installations of First Two Compact 1.0 GHz NMR Systems to Advance Structural Biology

Business Wire February 3, 2023

Bruker Announces Date and Time of Fourth Quarter 2022 Earnings Release and Webcast

Business Wire January 31, 2023

Bruker Announces Acquisition of ACQUIFER Imaging GmbH

Business Wire January 5, 2023

Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers

Business Wire January 4, 2023

Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference

Business Wire December 21, 2022

Bruker Energy & Supercon Technologies (BEST) Announces Multi-Year Orders for Key Magnetic Confinement Fusion Technologies

Business Wire December 16, 2022

Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio

Business Wire November 14, 2022

Bruker Announces Quarterly Dividend

Business Wire November 11, 2022

Bruker Announces Acquisition of Inscopix for Neuroscience Research

Business Wire November 8, 2022

Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference

Business Wire November 7, 2022

Bruker Reports Third Quarter 2022 Financial Results

Business Wire November 3, 2022

Bruker Announces Date and Time of Third Quarter 2022 Earnings Release and Webcast

Business Wire October 21, 2022

Bruker Launches New nanoElute® 2 nano-LC For 4D-Proteomics, Advances Fluxomics Applications with MetaboScape® 2023 Software

Business Wire August 29, 2022

Bruker Introduces Enabling New Scientific Capabilities for Cell Biology and Pathobiology Research with High-Field NMR Innovations

Business Wire August 22, 2022

Bruker Announces Quarterly Dividend

Business Wire August 12, 2022

Bruker Reports Second Quarter 2022 Financial Results

Business Wire August 3, 2022

Bruker Announces Date and Time of Second Quarter 2022 Earnings Release and Webcast

Business Wire July 25, 2022

Acuamark Diagnostics Secures $11.3 Million Series A Funding to Advance Innovative Assays for Improved, Cost-Effective Early-Cancer Detection

PR Newswire July 20, 2022